A new cancer drug, during a phase I trial, placed a patient with myelodysplastic syndrome in a complete remission that has lasted for more than three years. And it did so, in a non-invasive manner, setting forth a new way of treating cancer. CPI-613, a drug made by Cornerstone Pharmaceuticals, benefited 29 percent of cancer [...]
Apple's iPhone 6 and Apple Watch launch event on Tuesday was both wildly successful and simultaneously beset with bumps. Apple's livestream initially cut out. A Chinese translator frequently cut in. And the biggest disappointment: Apple's health care plans got cut from the program. After months of strategic leaks, Apple observers were ready for the company [...]
I must not be the only person to wonder how pharmaceutical companies succeed with direct to consumer advertisements when, stuck in the middle of all their TV ads, are those long lists of side effects. You know what I mean. After watching a smiling and attractive person running through a [...]
In recent years, the medical community has become increasingly aware that taking statins can result in slightly higher glucose levels, and this can lead to a diagnosis of diabetes in a small but statistically significant number of people. But it has been unclear whether the diagnosis of diabetes in people [...]
Based on a new study by the Substance Abuse and Mental Health Services Administration (SAMHSA), estimated emergency department (ED) visits involving zolpidem (commonly known as Ambien) overmedication almost doubled from 21,824 visits in 2005-2006 to 42,274 visits in 2009-2010. The report, "Emergency Department Visits Attributed to Overmedication That Involved the Insomnia [...]
Thanks to a pilot project announced today by Microsoft, TracFone and Health Choice Network (here) we're about to find out. Set to launch in January, the pilot project is designed to test the theory that smartphones can lower costs and manage chronic conditions like diabetes with better health outcomes. One big [...]
When surveyed about their outlook, pharma industry leaders said they felt plagued by uncertainty and beaten down by budget cuts. More than half worried they would receive pink slips by the end of this year.
Are generic drugs still the bargain that everyone thinks? A new analysis finds that half of all generic drugs sold through retailers became more expensive over the past 12 months. In fact, the prices paid by pharmacies more than doubled for one out of 11 generics.
There are certainly a number of good business reasons for one pharmaceutical company to merge or acquire another. However, as I have often said in the past and, as can be seen in this case, mergers can have a negative effect on the R&D division of a company.